These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk. Schooling CM. Lancet HIV; 2015 Sep; 2(9):e366. PubMed ID: 26423548 [No Abstract] [Full Text] [Related]
5. Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk. Hofmeyr GJ, Singata M, Lawrie TA, Temmerman M. Lancet HIV; 2015 Sep; 2(9):e365. PubMed ID: 26423546 [No Abstract] [Full Text] [Related]
8. Research on hormonal contraception and HIV. Cates W, Evidence for Contraceptive Options and HIV Outcomes (ECHO) Consortium. Lancet; 2014 Jan 25; 383(9914):303-4. PubMed ID: 24461116 [No Abstract] [Full Text] [Related]
13. The injectable contraceptive: present and future trends. Koetsawang S. Ann N Y Acad Sci; 1991 Jan 25; 626():30-42. PubMed ID: 1829341 [No Abstract] [Full Text] [Related]
14. Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis. Hapgood JP, Ray RM, Govender Y, Avenant C, Tomasicchio M. Am J Reprod Immunol; 2014 Jun 25; 71(6):505-12. PubMed ID: 24547700 [Abstract] [Full Text] [Related]
15. Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study. Byrne EH, Anahtar MN, Cohen KE, Moodley A, Padavattan N, Ismail N, Bowman BA, Olson GS, Mabhula A, Leslie A, Ndung'u T, Walker BD, Ghebremichael MS, Dong KL, Kwon DS. Lancet Infect Dis; 2016 Apr 25; 16(4):441-8. PubMed ID: 26723758 [Abstract] [Full Text] [Related]